Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/28/2011 | US7968310 Tagged sialyltransferase proteins |
06/28/2011 | US7968308 Isolating human antibodies |
06/28/2011 | US7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
06/28/2011 | US7968297 Hyperimmune serum-reactive antigen for use in prevention and treatment of tumor, allergen or metabolic disorders |
06/28/2011 | US7968100 Surface proteins from coagulase-negative staphylococci and Staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
06/28/2011 | US7968093 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
06/28/2011 | US7968092 Human binding molecule against CD1a |
06/28/2011 | US7968086 Genetically stable enterovirus expression vector with replaced stem loop VI |
06/28/2011 | CA2309783C Fibroblast growth factor-19 |
06/28/2011 | CA2222747C Dna sequence and encoded mammary-specific breast cancer protein |
06/23/2011 | WO2011075677A2 Methods for producing polypeptides in protease-deficient mutants of trichoderma |
06/23/2011 | WO2011075342A1 Promoter for regulation of gene expression in plant roots |
06/23/2011 | WO2011073367A1 Secretion system on the basis of a hydrophobin signal sequence from trichoderma reesei |
06/23/2011 | WO2011072596A1 Soluble collagen and preparation method and use thereof |
06/23/2011 | WO2011039519A3 ACETYL LYSINE INCORPORATION WITH tRNA SYNTHETASE |
06/23/2011 | WO2011039518A3 Incorporation of methyl lysine into polypeptides |
06/23/2011 | WO2011034622A9 Inducible self-cleaving protease tag and method of purifying recombinant proteins using the same |
06/23/2011 | WO2010141845A9 Immunoregulatory peptides and emthods of use |
06/23/2011 | WO2003056914A9 Methods to engineer mammalian-type carbohydrate structures |
06/23/2011 | US20110154540 Recombinant vectors carrying zearalenone-inducible promoter and methods for producing proteins and detecting zearalenone using them |
06/23/2011 | US20110154537 Novel Bacillus thuringiensis Gene with Coleopteran Activity |
06/23/2011 | US20110154536 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
06/23/2011 | US20110154535 Novel Bacillus thuringiensis Gene with Coleopteran Activity |
06/23/2011 | US20110154530 Plants with Increased Yield by Increasing or Generating One or More Activities in a Plant or a Part Thereof |
06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
06/23/2011 | US20110154519 Hafnia phytase |
06/23/2011 | US20110154515 Genetically encoded calcium sensors comprising the c-terminal lobe of troponin c and a fluorescence tag |
06/23/2011 | US20110154514 Polynucleotide used for releasing recombinant protein to the outside of eukaryotic cell |
06/23/2011 | US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders |
06/23/2011 | US20110152502 Fluorescent protein |
06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
06/23/2011 | US20110152341 Cleavage of b-amyloid precursor protein |
06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
06/23/2011 | US20110152171 Histamine binding protein |
06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
06/23/2011 | US20110151515 Production of fc-fusion polypeptides in eukaryotic algae |
06/23/2011 | US20110151514 Vectors, Methods, Systems and Kits for Protein Purification |
06/23/2011 | US20110151513 Shrna-mediated inhibition of expression of alpha-1,6-fucosyltransferase |
06/23/2011 | US20110151512 Oligopeptide-free cell culture media |
06/23/2011 | US20110151511 Rapid growing microorganisms for biotechnology applications |
06/23/2011 | US20110151510 Functional molecule and manufacturing method therefor |
06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
06/23/2011 | US20110151433 Methods for production of unstructured recombinant polymers and uses thereof |
06/23/2011 | US20110151100 Green Process for Production of Biosurfactants or Biopolymers through Waste Oil Utilization |
06/23/2011 | US20110151005 Methods and means for soft tissue engineering |
06/23/2011 | US20110150903 Fgf-r4 receptor-specific antagonists |
06/23/2011 | US20110150901 Binding proteins that bind to human fgfr1c, human beta-klotho and both human fgfr1c and human beta-klotho |
06/23/2011 | US20110150892 Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof |
06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
06/23/2011 | US20110150874 Fusion proteins, uses thereof and processes for producing same |
06/23/2011 | US20110150867 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
06/23/2011 | US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof |
06/23/2011 | CA2784599A1 Methods for producing polypeptides in protease-deficient mutants of trichoderma |
06/23/2011 | CA2783005A1 Promoter for regulation of gene expression in plant roots |
06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
06/22/2011 | EP2336334A1 Nucleic acid constructs and methods for producing altered seed oil compositions |
06/22/2011 | EP2336313A1 Methods for production of proteins |
06/22/2011 | EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof |
06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
06/22/2011 | EP2336186A1 Humanized antibodies against ICAM-1, their production and uses |
06/22/2011 | EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
06/22/2011 | EP2336173A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
06/22/2011 | EP2336149A1 Protein purification method |
06/22/2011 | EP2335728A1 Specific binding proteins and uses thereof |
06/22/2011 | EP2334803A1 Small scale shaker flask cultivation |
06/22/2011 | EP2334706A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
06/22/2011 | EP1917363B1 Method for making mature insulin polypeptides |
06/22/2011 | EP1724342B1 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli |
06/22/2011 | EP1680507B1 Bacterial expression of protease inhibitors and variants thereof |
06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
06/22/2011 | CN1875920B Recombinant human serum albumin and yeast ferment mixture, composition containing said mixture, preparation process and use thereof |
06/22/2011 | CN1244896B Non-M, non-O, HIV-1 strains, fragments and applications |
06/22/2011 | CN102105490A Fucose a1-6-specific lectin |
06/22/2011 | CN102105163A Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof |
06/22/2011 | CN102102119A Bird's nest oligopeptide composition and preparation method and use thereof |
06/22/2011 | CN102102118A Method for preparing L-ornithine-L-aspartate salt |
06/22/2011 | CN102102117A Culture medium for antihypertensive peptide engineering bacteria |
06/22/2011 | CN102101884A Preparation method and use of donkey-hide gelatin polypeptide |
06/22/2011 | CN101586112B Gene cluster for biological synthesis of Nosiheptide |
06/22/2011 | CN101538266B Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |
06/22/2011 | CN101396378B Nano gene peptides products and preparation method and use thereof |
06/22/2011 | CN101284876B Fusion protein Penharpin, preparation method and use |
06/21/2011 | US7966338 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
06/21/2011 | US7964767 Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodies |
06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
06/21/2011 | US7964707 Anti-IL2 antibodies |
06/21/2011 | US7964705 Humaneered anti-factor B antibody |
06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
06/21/2011 | US7964398 Modified vaccinia ankara virus variant and cultivation method |